|
⚲
|
| Keyboard |
| Staab Thomas R II
✚
|
|
|---|---|
| CIK # | 0001230708 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001230708] | |
| 4 | [0001230708] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tenax Therapeutics Inc | |
| Staab Thomas R II | |
| Lensar Inc | |
| Biocryst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lensar Inc LNSR
Common Stock
|
2026-03-19 | Option exercise | 5,500 | $2.65 | 14,575 |
|
Lensar Inc LNSR
Stock Option (Right to Buy) · derivative
|
2026-03-19 | Option exercise | 5,500 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2026-02-18 | Tax withheld | 1,076 | $11.32 | 12,180 |
|
Lensar Inc LNSR
Common Stock
|
2026-01-11 | Tax withheld | 1,826 | $11.57 | 21,127 |
|
Lensar Inc LNSR
Common Stock
|
2025-02-18 | Grant | 12,766 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2025-01-11 | Tax withheld | 1,839 | $8.25 | 15,172 |
|
Lensar Inc LNSR
Stock Option (Right to Buy) · derivative
|
2024-08-08 | Option exercise | 3,500 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2024-08-08 | Option exercise | 3,500 | $2.65 | 9,275 |
|
Lensar Inc LNSR
Common Stock
|
2024-05-06 | Grant | 19,000 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2024-01-11 | Tax withheld | 1,853 | $4.43 | 8,209 |
|
Lensar Inc LNSR
Common Stock
|
2023-01-11 | Grant | 6,656 | $0.00 | |
|
Lensar Inc LNSR
Stock Option (Right to Buy) · derivative
|
2023-01-11 | Grant | 23,295 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2022-12-07 | Buy | 727 | $3.16 | 2,297 |
|
Lensar Inc LNSR
Common Stock
|
2022-12-06 | Buy | 2,025 | $3.16 | 6,399 |
|
Lensar Inc LNSR
Common Stock
|
2022-01-11 | Grant | 15,000 | $0.00 | |
|
Lensar Inc LNSR
Stock Option (Right to Buy) · derivative
|
2022-01-11 | Grant | 52,500 | $0.00 | |
|
Lensar Inc LNSR
Stock Option (Right to Buy) · derivative
|
2021-04-12 | Grant | 49,197 | $0.00 | |
|
Lensar Inc LNSR
Common Stock
|
2020-12-07 | Grant | 19,276 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2020-02-21 | Grant | 18,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2020-02-14 | Grant | 31,500 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||